269 related articles for article (PubMed ID: 29169339)
1. An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment.
Huebner D; Rieger C; Bergmann R; Ullrich M; Meister S; Toma M; Wiedemuth R; Temme A; Novotny V; Wirth MP; Bachmann M; Pietzsch J; Fuessel S
BMC Cancer; 2017 Nov; 17(1):790. PubMed ID: 29169339
[TBL] [Abstract][Full Text] [Related]
2. Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.
Kim S; Zhang Y; Tang S; Qin C; Karelia D; Sharma A; Jiang C; Lu J
Prostate; 2019 Jun; 79(9):949-960. PubMed ID: 30958914
[TBL] [Abstract][Full Text] [Related]
3. Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis.
van der Horst G; van Asten JJ; Figdor A; van den Hoogen C; Cheung H; Bevers RF; Pelger RC; van der Pluijm G
Eur Urol; 2011 Aug; 60(2):337-43. PubMed ID: 21616583
[TBL] [Abstract][Full Text] [Related]
4. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
Hadaschik BA; Black PC; Sea JC; Metwalli AR; Fazli L; Dinney CP; Gleave ME; So AI
BJU Int; 2007 Dec; 100(6):1377-84. PubMed ID: 17850390
[TBL] [Abstract][Full Text] [Related]
5. P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor model.
Chi BH; Kim SJ; Seo HK; Seo HH; Lee SJ; Kwon JK; Lee TJ; Chang IH
J Korean Med Sci; 2015 Mar; 30(3):308-16. PubMed ID: 25729255
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of a human bladder cancer cell line stably co-expressing hSPRY2 and luciferase genes and its subcutaneous tumor xenograft model in nude mice].
Yin X; Li F; Jin Y; Yin Z; Qi S; Wu S; Wang Z; Wang L; Yu J; Gao J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Mar; 33(3):337-341. PubMed ID: 28274312
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.
Mugabe C; Matsui Y; So AI; Gleave ME; Baker JH; Minchinton AI; Manisali I; Liggins R; Brooks DE; Burt HM
Clin Cancer Res; 2011 May; 17(9):2788-98. PubMed ID: 21357680
[TBL] [Abstract][Full Text] [Related]
8. Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis.
Moret R; Hellmers L; Zhang X; Gills J; Hite N; Klinger A; Maresh GA; Canter D; Bardot S; Margolin DA; Li L
J Vis Exp; 2019 May; (147):. PubMed ID: 31132059
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
[TBL] [Abstract][Full Text] [Related]
10. Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma.
Haldorsen IS; Popa M; Fonnes T; Brekke N; Kopperud R; Visser NC; Rygh CB; Pavlin T; Salvesen HB; McCormack E; Krakstad C
PLoS One; 2015; 10(8):e0135220. PubMed ID: 26252891
[TBL] [Abstract][Full Text] [Related]
11. [Establishment and application of an orthotopic murine bladder cancer model].
Yang SM; Wen DG; Hou JQ; He J; Cen JN; Chen JH
Ai Zheng; 2007 Apr; 26(4):341-5. PubMed ID: 17430648
[TBL] [Abstract][Full Text] [Related]
12. Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the mammalian target of rapamycin signaling pathway.
Kim SJ; Seo HK; Seo HH; Lee SJ; Kwon JK; Lee TJ; Chi BH; Chang IH
J Korean Med Sci; 2014 Mar; 29(3):343-50. PubMed ID: 24616582
[TBL] [Abstract][Full Text] [Related]
13. A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis.
Gills J; Moret R; Zhang X; Nelson J; Maresh G; Hellmers L; Canter D; Hudson M; Halat S; Matrana M; Marino MP; Reiser J; Shuh M; Laborde E; Latsis M; Talwar S; Bardot S; Li L
Oncotarget; 2018 Aug; 9(66):32718-32729. PubMed ID: 30220977
[TBL] [Abstract][Full Text] [Related]
14. Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model.
Chan ES; Patel AR; Smith AK; Klein JB; Thomas AA; Heston WD; Larchian WA
J Urol; 2009 Dec; 182(6):2926-31. PubMed ID: 19846165
[TBL] [Abstract][Full Text] [Related]
15. Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.
Raven PA; D'Costa NM; Moskalev I; Tan Z; Frees S; Chavez-Munoz C; So AI
Am J Clin Exp Urol; 2018; 6(6):245-259. PubMed ID: 30697580
[TBL] [Abstract][Full Text] [Related]
16. Minimally invasive establishment of murine orthotopic bladder xenografts.
Jäger W; Moskalev I; Janssen C; Hayashi T; Gust KM; Awrey S; Black PC
J Vis Exp; 2014 Feb; (84):e51123. PubMed ID: 24561487
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach.
Jäger W; Moskalev I; Janssen C; Hayashi T; Awrey S; Gust KM; So AI; Zhang K; Fazli L; Li E; Thüroff JW; Lange D; Black PC
PLoS One; 2013; 8(3):e59536. PubMed ID: 23555699
[TBL] [Abstract][Full Text] [Related]
18. A Non-invasive Imageable GFP-expressing Mouse Model of Orthotopic Human Bladder Cancer.
Sun YU; Nishino H; Zhao M; Miyake K; Sugisawa N; Yamamoto J; Tashiro Y; Inubushi S; Hamada K; Zhu G; Lim H; Hoffman RM
In Vivo; 2020; 34(6):3225-3231. PubMed ID: 33144427
[TBL] [Abstract][Full Text] [Related]
19. Mouse orthotopic models for bladder cancer research.
Chan E; Patel A; Heston W; Larchian W
BJU Int; 2009 Nov; 104(9):1286-91. PubMed ID: 19388981
[TBL] [Abstract][Full Text] [Related]
20. Orthotopic Mouse Models of Urinary Bladder Cancer.
Noh JI; Ahn EJ; Noh MG; Moon KS; Chung E; Choi C; Lee KH; Kim SS
In Vivo; 2023; 37(5):2039-2043. PubMed ID: 37652486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
